Form 4: ANI Pharmaceuticals SVP, CHIEF HR OFFICER, Krista Davis, Sells Shares
SEC Form 4
Krista Davis, SVP, CHIEF HR OFFICER of ANI Pharmaceuticals, sold 1,866 shares of common stock at $65 per share on March 19, 2025, according to a Form 4 filing.
Summary
- Krista Davis, the SVP, CHIEF HR OFFICER of ANI Pharmaceuticals, sold 1,866 shares of common stock on March 19, 2025.
- The shares were sold at a price of $65 per share.
- Following the transaction, Davis directly owns 64,659 shares of ANI Pharmaceuticals.
- The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 23, 2024.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard disclosure of an insider stock sale under a pre-arranged trading plan. It doesn't inherently indicate positive or negative news about the company.
Industry Context
This is a routine disclosure of an insider transaction. It's common for executives to sell shares for personal financial management, often under pre-arranged trading plans to avoid accusations of insider trading.
Stakeholder Impact
- The sale of shares by an executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 2024-08-23 | Date of adoption of Rule 10b5-1 trading plan |
| 2025-03-19 | Date of stock sale transaction |
| 2025-03-20 | Date of signature on the Form 4 filing |
Keywords
Form 4, ANI Pharmaceuticals, ANIP, Krista Davis, stock sale, Rule 10b5-1 plan, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.